Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Levtec Pharmaceutical is a prominent Chinese pharmaceutical enterprise headquartered in Haikou, Hainan. Founded in 1994, the company focuses on the development, production, and distribution of high-quality generic medications across several therapeutic areas, including cardiovascular, anti-infective, and metabolic diseases. Its most recognized product is the Letai brand of Amlodipine Besylate, which has established a strong market position in China for treating hypertension. The company operates modern, GMP-compliant manufacturing bases and is committed to providing affordable healthcare solutions through its extensive domestic sales network. As a recognized high-tech enterprise, Hainan Levtec continues to expand its portfolio to address a wide range of chronic and acute conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Levtec Pharmaceutical.